Co-Diagnostics develops ebola test strategy with CoSara joint venture
Go back to Co-Diagnostics develops ebola test strategy with CoSara joint venture| (NASDAQ: CODX) | Delayed: 3.30 +0.18 (5.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.12 | 52 Week High | $ | |||
| Open | $3.03 | 52 Week Low | $ | |||
| Day High | $3.51 | P/E | N/A | |||
| Day Low | $2.97 | EPS | $ | |||
| Volume | 285,089 | |||||
